- Home
- ELA vs LYEL Comparison
ELA vs LYEL Comparison
Compare ELA & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELA | LYEL |
|---|---|---|
| Founded | 1965 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.7M | 490.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELA | LYEL |
|---|---|---|
| Price | $17.53 | $23.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $16.50 | ★ $30.60 |
| AVG Volume (30 Days) | ★ 163.5K | 79.7K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.38 | N/A |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $241,021,362.00 | $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.54 | $16,285.34 |
| P/E Ratio | $31.09 | ★ N/A |
| Revenue Growth | ★ 33.62 | N/A |
| 52 Week Low | $5.33 | $0.39 |
| 52 Week High | $18.29 | $45.00 |
Technical Indicators
Market Signals| Indicator | ELA | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 65.47 | 55.91 |
| Support Level | $16.09 | $21.27 |
| Resistance Level | $18.29 | $27.30 |
| Average True Range (ATR) | 0.78 | 1.70 |
| MACD | -0.02 | 0.53 |
| Stochastic Oscillator | 71.34 | 75.83 |
Price Performance
Historical ComparisonAbout ELA Envela Corporation
Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. It operates through two segments, Consumer and Commercial Services. The Consumer segment, which generates key revenue for the company, predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins, and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.